Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.970
-0.110 (-2.70%)
Nov 20, 2024, 4:00 PM EST - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 862 employees as of December 31, 2023. The number of employees decreased by 168 or -16.31% compared to the previous year.
Employees
862
Change (1Y)
-168
Growth (1Y)
-16.31%
Revenue / Employee
$527,886
Profits / Employee
-$8,561
Market Cap
526.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Auna S.A. | 14,958 |
Fulgent Genetics | 1,184 |
CureVac | 1,172 |
Talkspace | 472 |
Astria Therapeutics | 59 |
GH Research | 49 |
Savara | 37 |
Opthea | 33 |
ORGO News
- 6 days ago - Organogenesis Commends Final LCDs - GlobeNewsWire
- 8 days ago - Organogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock - GlobeNewsWire
- 9 days ago - Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis - GlobeNewsWire
- 5 weeks ago - Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 7 weeks ago - Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 3 months ago - Organogenesis Holdings, Inc. (ORGO) Q2 2024 Earnings Call Transcript - Seeking Alpha